OFF-BRAND IMATINIB: A BUDGET-FRIENDLY OPTION?

The emergence of generic imatinib represents a notable possibility for patients battling a certain type of cancer and other conditions. Original brand-name imatinib, commonly known as Gleevec, carries a considerable price cost, frequently presenting a challenge for accessibility for some individu